Outlook Therapeutics (OTLK) Return on Capital Employed Growth (3y) (2019 - 2026)
Outlook Therapeutics (OTLK) Return on Capital Employed Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
51.13 Mn |
43.39 Mn |
-21,888.00 |
68,294.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
68,294.00 |
| Dec 31, 2025 |
40,726.00 |
| Sep 30, 2025 |
72,090.00 |
| Jun 30, 2025 |
85,535.00 |
| Mar 31, 2025 |
126,352.00 |
| Dec 31, 2024 |
49,230.00 |
| Sep 30, 2024 |
180,524.00 |
| Jun 30, 2024 |
-33,378.00 |
| Mar 31, 2024 |
142,682.00 |
| Dec 31, 2023 |
132,236.00 |
| Sep 30, 2023 |
104,050.00 |
| Jun 30, 2023 |
908,585.00 |
| Mar 31, 2023 |
-64,053.00 |
| Dec 31, 2022 |
-75,636.00 |
| Sep 30, 2022 |
28,706.00 |
| Jun 30, 2022 |
164,347.00 |
| Mar 31, 2022 |
-55,176.00 |
| Dec 31, 2021 |
-68,626.00 |
| Sep 30, 2021 |
-101,375.00 |
| Jun 30, 2021 |
-176,734.00 |
